Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience
Fine, Robert L., Gulati, Anthony P., Krantz, Benjamin A., Moss, Rebecca A., Schreibman, Stephen, Tsushima, Dawn A., Mowatt, Kelley B., Dinnen, Richard D., Mao, Yuehua, Stevens, Peter D., Schrope, Beth, Allendorf, John, Lee, James A., Sherman, William H., Chabot, John A.
Published in Cancer chemotherapy and pharmacology (01.03.2013)
Published in Cancer chemotherapy and pharmacology (01.03.2013)
Get full text
Journal Article
New-onset persistent hyperglycemia with initiation of brentuximab treatment
Quintas, Joseph, Mowatt, Kelley B, Mullally, Jamie A, Steinberg, Amir
Published in Journal of oncology pharmacy practice (28.04.2023)
Published in Journal of oncology pharmacy practice (28.04.2023)
Get more information
Journal Article
Treatment of Multiple Endocrine Neoplasia 1/2 Tumors: Case Report and Review of the Literature
Gulati, Anthony P., Krantz, Benjamin, Moss, Rebecca A., Moyal, Wendy N., Tsushima, Dawn A., Mowatt, Kelley B., Schreibman, Stephen, Fine, Robert L.
Published in Oncology (01.01.2013)
Published in Oncology (01.01.2013)
Get full text
Journal Article
New Onset Persistent Hyperglycemia with Initiation of Brentuximab Treatment
Quintas, Joseph B., Mowatt, Kelley B., Mullally, Jamie A., Steinberg, Amir
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Incidental Krukenberg Tumor During Cesarean Section
Delgado-Lazo, Victor, Syed, Rizwana, Mowatt, Kelley B., Popescu-Martinez, Andrea
Published in Annals of Internal Medicine: Clinical Cases (01.10.2022)
Published in Annals of Internal Medicine: Clinical Cases (01.10.2022)
Get full text
Journal Article
Prospective phase II study of capecitabine and temozolomide (CAPTEM) for progressive, moderately, and well-differentiated metastatic neuroendocrine tumors
Fine, Robert Lance, Gulati, Anthony Paul, Tsushima, Dawn, Mowatt, Kelley B., Oprescu, Anna, Bruce, Jeffrey N., Chabot, John A.
Published in Journal of clinical oncology (20.01.2014)
Published in Journal of clinical oncology (20.01.2014)
Get full text
Journal Article
Prospective phase II study of inoperable pancreatic adenocarcinoma with neoadjuvant gemcitabine, docetaxel, and capecitabine (GTX)
Gulati, Anthony Paul, Schreibman, Stephen M., Schrope, Beth, Lee, James A., Allendorf, John, Chabot, John A., Tsushima, Dawn, Mowatt, Kelley B., Oprescu, Anna, Chu, Kyung, Sherman, William H., Ennis, Ronald D., Lee, Yoomi, Fine, Robert Lance
Published in Journal of clinical oncology (20.01.2014)
Published in Journal of clinical oncology (20.01.2014)
Get full text
Journal Article
Prospective phase II trial of GTX in metastatic pancreatic cancer: Laboratory and clinical studies
Fine, Robert, Lee, Yoomi, Sherman, William H., Gulati, Anthony Paul, Oberstein, Paul Eliezer, Chu, Kyung, Tsushima, Dawn, Mowatt, Kelley B, Schrope, Beth, Lee, James A, Allendorf, John, Chabot, John A, Schreibman, Stephen M.
Published in Journal of clinical oncology (01.02.2013)
Published in Journal of clinical oncology (01.02.2013)
Get full text
Journal Article
The efficacy and safety of the capecitabine/temozolomide (CAPTEM) regimen in the treatment of well-differentiated neuroendocrine tumors with liver metastasis after failure of previous therapy: Columbia University Medical Center experience
Oberstein, Paul Eliezer, Gulati, Anthony Paul, Krantz, Benjamin A, Moss, Rebecca Anne, Schreibman, Stephen M., Tsushima, Dawn, Mowatt, Kelley B, Allendorf, John, Schrope, Beth, Lee, James A, Sherman, William H., Chabot, John A, Fine, Robert
Published in Journal of clinical oncology (01.02.2013)
Published in Journal of clinical oncology (01.02.2013)
Get full text
Journal Article